Sign In

Login

Password

Forgot Password ? Sign Up

トリヘキシフェニジル (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "トリヘキシフェニジル" in Japanese language version.

refsWebsite
Global rank Japanese rank
12nih.gov
4th place
24th place
7doi.org
2nd place
6th place
2tga.gov.au
3,984th place
low place
2pmda.go.jp
6,690th place
394th place
1fda.gov
447th place
1,043rd place
1webmd.com
1,169th place
1,632nd place
1medscape.com
719th place
3,311th place
1drugs.com
399th place
1,603rd place

doi.org

  • “Movement disorders”. The Medical Clinics of North America. Common Neurologic Disorders 93 (2): 371–88, viii. (March 2009). doi:10.1016/j.mcna.2008.09.002. PMID 19272514. 
  • “[Drug-Induced Akathisia]”. Brain and Nerve = Shinkei Kenkyu No Shinpo 69 (12): 1417–1424. (December 2017). doi:10.11477/mf.1416200927. PMID 29282345. 
  • “Drug-induced movement disorders”. Australian Prescriber 42 (2): 56–61. (April 2019). doi:10.18773/austprescr.2019.014. PMC 6478951. PMID 31048939. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478951/. 
  • “Five year follow-up of treatment with trihexyphenidyl (artane); outcome in four hundred eleven cases of paralysis agitans”. Journal of the American Medical Association 154 (16): 1334–6. (April 1954). doi:10.1001/jama.1954.02940500014005. PMID 13151847. 
  • “Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine”. British Journal of Pharmacology 89 (1): 83–90. (September 1986). doi:10.1111/j.1476-5381.1986.tb11123.x. PMC 1917044. PMID 2432979. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1917044/. 
  • “Addiction, dopamine, and the molecular mechanisms of memory”. Neuron 25 (3): 515–32. (March 2000). doi:10.1016/S0896-6273(00)81056-9. PMID 10774721. 
  • “Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy”. Journal of Child Neurology 22 (5): 530–7. (May 2007). doi:10.1177/0883073807302601. PMID 17690057. 

drugs.com

fda.gov

accessdata.fda.gov

medscape.com

reference.medscape.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • “Movement disorders”. The Medical Clinics of North America. Common Neurologic Disorders 93 (2): 371–88, viii. (March 2009). doi:10.1016/j.mcna.2008.09.002. PMID 19272514. 
  • “[Drug-Induced Akathisia]”. Brain and Nerve = Shinkei Kenkyu No Shinpo 69 (12): 1417–1424. (December 2017). doi:10.11477/mf.1416200927. PMID 29282345. 
  • “Drug-induced movement disorders”. Australian Prescriber 42 (2): 56–61. (April 2019). doi:10.18773/austprescr.2019.014. PMC 6478951. PMID 31048939. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478951/. 
  • “Five year follow-up of treatment with trihexyphenidyl (artane); outcome in four hundred eleven cases of paralysis agitans”. Journal of the American Medical Association 154 (16): 1334–6. (April 1954). doi:10.1001/jama.1954.02940500014005. PMID 13151847. 
  • “Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine”. British Journal of Pharmacology 89 (1): 83–90. (September 1986). doi:10.1111/j.1476-5381.1986.tb11123.x. PMC 1917044. PMID 2432979. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1917044/. 
  • “Addiction, dopamine, and the molecular mechanisms of memory”. Neuron 25 (3): 515–32. (March 2000). doi:10.1016/S0896-6273(00)81056-9. PMID 10774721. 
  • “Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy”. Journal of Child Neurology 22 (5): 530–7. (May 2007). doi:10.1177/0883073807302601. PMID 17690057. 

ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

toxnet.nlm.nih.gov

pmda.go.jp

info.pmda.go.jp

tga.gov.au

ebs.tga.gov.au

webmd.com

  • “Trihexyphenidyl”. Web MD. First Databank Inc. 2021年6月11日閲覧。